{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:39Z","timestamp":1707524259965},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,26]]},"DOI":"10.7759\/cureus.16642","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:39:21Z","timestamp":1627324761000},"source":"Crossref","is-referenced-by-count":0,"title":["Kidney Transplant Recipient With Multiple Contemporaneous Malignancies Secondary to Muir-Torre Syndrome"],"prefix":"10.7759","author":[{"given":"Ahmed T","family":"Qudaih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan H","family":"Al Ashour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman k","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani A","family":"Joudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800540309","article-title":"Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face","volume":"54","author":"Muir EG","year":"1967","unstructured":"Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967, 54:191-5. 10.1002\/bjs.1800540309","journal-title":"Br J Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.98.5.549","article-title":"Multiple sebaceous tumors","volume":"98","author":"Torre D","year":"1968","unstructured":"Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968, 98:549-51. 10.1001\/archderm.98.5.549","journal-title":"Arch Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90017-9","article-title":"The Muir-Torre syndrome: a 25-year retrospect","volume":"33","author":"Schwartz R","year":"1995","unstructured":"Schwartz R, Torre D. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995, 33:90-104. 10.1016\/0190-9622(95)90017-9","journal-title":"J Am Acad Dermatol"},{"key":"ref4","article-title":"Muir-Torre Syndrome","author":"Gay J","year":"2020","unstructured":"Gay J, Troxell T, Gross G. Muir-Torre Syndrome. StatPearls Publishing, Treasure Island; 2020."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70465-4","article-title":"Muir-Torre syndrome","volume":"6","author":"Ponti G","year":"2005","unstructured":"Ponti G, de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005, 6:980-7. 10.1016\/S1470-2045(05)70465-4","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.074","article-title":"Muir-Torre syndrome (MTS): An update and approach to diagnosis and management","volume":"74","author":"John AM","year":"2016","unstructured":"John AM, Schwartz RA. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management. J Am Acad Dermatol. 2016, 74:558-66. 10.1016\/j.jaad.2015.09.074","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JDN.0000000000000293","article-title":"Muir-Torre syndrome","volume":"9","author":"Roybal L","year":"2017","unstructured":"Roybal L, Carlson K. Muir-Torre syndrome. J Dermatol Nurses Assoc. 2017, 9:88-90. 10.1097\/JDN.0000000000000293","journal-title":"J Dermatol Nurses Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290705.x","article-title":"Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome","volume":"29","author":"Machin P","year":"2002","unstructured":"Machin P, Catasus L, Pons C, et al.. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002, 29:415-20. 10.1034\/j.1600-0560.2002.290705.x","journal-title":"J Cutan Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/301926","article-title":"Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria","volume":"63","author":"Kruse R","year":"1998","unstructured":"Kruse R, R\u00fctten A, Lamberti C, et al.. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998, 63:63-70. 10.1086\/301926","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30110-4","article-title":"Muir-Torre syndrome","volume":"13","author":"Cohen P","year":"1995","unstructured":"Cohen P, Kohn S, Davis D, Kurzrock R. Muir-Torre syndrome. Dermatol Clin. 1995, 13:79-89. 10.1016\/S0733-8635(18)30110-4","journal-title":"Dermatol Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-012-9552-4","article-title":"Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms","volume":"22","author":"Roberts ME","year":"2013","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC, et al.. Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. J Genet Couns. 2013, 22:393-405. 10.1007\/s10897-012-9552-4","journal-title":"J Genet Couns"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20873","article-title":"Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry","volume":"103","author":"Ponti G","year":"2005","unstructured":"Ponti G, Losi L, Di Gregorio C, et al.. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer. 2005, 103:1018-25. 10.1002\/cncr.20873","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06506.x","article-title":"Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families","volume":"152","author":"Ponti G","year":"2005","unstructured":"Ponti G, Ponz de Leon M, Losi L, et al.. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Br J Dermatol. 2005, 152:1335-8. 10.1111\/j.1365-2133.2005.06506.x","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.19","article-title":"A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome","volume":"16","author":"Roberts ME","year":"2014","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC, et al.. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med. 2014, 16:711-6. 10.1038\/gim.2014.19","journal-title":"Genet Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1592-7","article-title":"Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report","volume":"20","author":"Tomonari M","year":"2019","unstructured":"Tomonari M, Shimada M, Nakada Y, et al.. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report. BMC Nephrol. 2019, 20:394. 10.1186\/s12882-019-1592-7","journal-title":"BMC Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01648.x","article-title":"Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome","volume":"7","author":"Levi Z","year":"2007","unstructured":"Levi Z, Hazazi R, Kedar-Barnes I, et al.. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transplant. 2007, 7:476-9. 10.1111\/j.1600-6143.2006.01648.x","journal-title":"Am J Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63181-kidney-transplant-recipient-with-multiple-contemporaneous-malignancies-secondary-to-muir-torre-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:55Z","timestamp":1707506875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63181-kidney-transplant-recipient-with-multiple-contemporaneous-malignancies-secondary-to-muir-torre-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.16642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,26]]}}}